A blood based 12-miRNA signature of Alzheimer disease patients

Genome Biology

Volumn 14, Issue 7, 2013, Pages

  Leidinger, Petra ^a   Backes, Christina ^a   Deutscher, Stephanie ^a   Schmitt, Katja ^a   Mueller, Sabine C ^a   Frese, Karen ^b   Haas, Jan ^b   Ruprecht, Klemens ^c   Paul, Friedemann ^c   Stähler, Cord ^d   Lang, Christoph J G ^e   Meder, Benjamin ^b   Bartfai, Tamas ^f   Meese, Eckart ^a   Keller, Andreas ^a,d  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d SIEMENS AG   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer disease; Biomarker; miRNA; Next generation sequencing; Quantitative real time PCR

Indexed keywords

BRAIN MIR 112; BRAIN MIR 161; HSA LET 7D 3P; HSA LET 7F 5P; HSA MIR 103A 3P; HSA MIR 1285 5P; HSA MIR 151A 3P; HSA MIR 26A 5P; HSA MIR 26B 5P; HSA MIR 5010 3P; HSA MIR 532 5P; MICRORNA; MICRORNA 107; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NERVE PROJECTION; NERVOUS SYSTEM DEVELOPMENT; NEXT GENERATION SEQUENCING; PARKINSON DISEASE; PREDICTION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BLOOD; BRAIN; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84880956260     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2013-14-7-r78     Document Type: Article

References (72)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM: Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
2. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88:1337-1342.
3. Gandy S: Perspective: prevention is better than cure. Nature 2011, 475: S15.
4. Deutsche Gesellschaft für Psychiatrie PuND, (DGN) DGfrN: S3-Leitlinie "Demenzen" 2009.
5. Fita IG, Enciu AM, Stanoiu BP: New insights on Alzheimer's disease diagnostic. Rom J Morphol Embryol 2011, 52:975-979.
6. Frankfort SV, Tulner LR, van Campen JP, Verbeek MM, Jansen RW, Beijnen JH: Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol 2008, 3:123-131.
7. Malaplate-Armand C, Desbene C, Pillot T, Olivier JL: [Biomarkers for early diagnosis of Alzheimer's disease: current update and future directions]. Rev Neurol (Paris) 2009, 165:511-520.
8. Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte SB, Alkon D, Etcheberrigaray R, Gibson G, Blass J, Paoletti R, Govoni S: Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J 1998, 12:17-34.
9. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, et al: The role of variation at AbetaPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis 2012, 28:377-387.
10. Hudson G, Sims R, Harold D, Chapman J, Hollingworth P, Gerrish A, Russo G, Hamshere M, Moskvina V, Jones N, Thomas C, Stretton A, Holmans PA, O'Donovan MC, Owen MJ, Williams J, Chinnery PF: No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 2012, 78:1038-1042.
11. Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN: Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 2012, 69:1-8.
12. Tan M, Wang S, Song J, Jia J: Combination of p53(ser15) and p21/p21 (thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers. Neurosci Lett 2012, 516:226-231.
13. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Muller- Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, et al: Toward the bloodborne miRNome of human diseases. Nat Methods 2011, 8:841-843.
14. Liang Y, Ridzon D, Wong L, Chen C: Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166.
15. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B: Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008, 105:6415-6420.
16. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT: The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008, 28:1213-1223.
17. Geekiyanage H, Chan C: MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J Neurosci 2011, 31:14820-14830.
18. Long JM, Lahiri DK: MicroRNA-101 downregulates Alzheimer's amyloidbeta precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 2010, 404:889-895.
19. Geekiyanage H, Jicha GA, Nelson PT, Chan C: Blood serum miRNA: noninvasive biomarkers for Alzheimer's disease. Exp Neurol 2011, 235:491-496.
20. Braskie MN, Toga AW, Thompson PM: Recent advances in imaging Alzheimer's disease. J Alzheimers Dis 2013, Suppl 1: S313-327.
21. miRBase.
22. Kozomara A, Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2010, 39:D152-157.
23. TAM-tool for annotations of human miRNAs. [http://202.38.126.151/hmdd/tools/tam.html].
24. Lu M, Shi B, Wang J, Cao Q, Cui Q: TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics 2010, 11:419.
25. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss- Coray T: Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007, 13:1359-1362.
26. Eacker SM, Dawson TM, Dawson VL: Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 2009, 10:837-841.
27. Villa C, Fenoglio C, De Riz M, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Cortini F, Serpente M, Cantoni C, Fumagalli G, Martinelli Boneschi F, Cappa S, Binetti G, Franceschi M, Rainero I, Giordana MT, Mariani C, Bresolin N, Scarpini E, Galimberti D: Role of hnRNP-A1 and miR- 590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuvenation Res 2011, 14:275-281.
28. Schipper HM, Maes OC, Chertkow HM, Wang E: MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio 2007, 1:263-274.
29. Maes OC, Xu S, Yu B, Chertkow HM, Wang E, Schipper HM: Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 2007, 28:1795-1809.
30. Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H, Liu Y, Ma C, Huang L, Zhang L, Qin C: miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res 2010, 1357:166-174.
31. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B: MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 2009, 33:422-428.
32. Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, Ishida T, Satoh J: Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 2010, 36:320-330.
33. Delay C, Calon F, Mathews P, Hebert SS: Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener 2011, 6:70.
34. Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T, Gotz J: Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 2010, 5:e11070.
35. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C: Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 2010, 31:224-243.
36. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE: Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005, 77:918-936.
37. Guo SZ, Huang K, Shi YY, Tang W, Zhou J, Feng GY, Zhu SM, Liu HJ, Chen Y, Sun XD, He L: A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr Res 2007, 93:385-390.
38. Treutlein J, Muhleisen TW, Frank J, Mattheisen M, Herms S, Ludwig KU, Treutlein T, Schmael C, Strohmaier J, Bosshenz KV, Breuer R, Paul T, Witt SH, Schulze TG, Schlosser RG, Nenadic I, Sauer H, Becker T, Maier W, Cichon S, Nothen MM, Rietschel M: Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter. Schizophr Res 2009, 111:123-130.
39. Tsunekawa Y, Britto JM, Takahashi M, Polleux F, Tan SS, Osumi N: Cyclin D2 in the basal process of neural progenitors is linked to non-equivalent cell fates. EMBO J 2012, 31:1879-1892.
40. Bauer AS, Keller A, Costello E, Greenhalf W, Bier M, Borries A, Beier M, Neoptolemos J, Buchler M, Werner J, Giese N, Hoheisel JD: Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 2012, 7:e34151.
41. Fenoglio C, Ridolfi E, Galimberti D, Scarpini E: MicroRNAs as active players in the pathogenesis of multiple sclerosis. Int J Mol Sci 2012, 13:13227-13239.
42. Waters PS, McDermott AM, Wall D, Heneghan HM, Miller N, Newell J, Kerin MJ, Dwyer RM: Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PLoS One 2012, 7:e50459.
43. Human MiRNA & Disease Database.
44. Nelson PT, Wang WX: MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis 2010, 21:75-79.
45. Augustin R, Endres K, Reinhardt S, Kuhn PH, Lichtenthaler SF, Hansen J, Wurst W, Trumbach D: Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet 2012, 13:35.
46. Yao J, Hennessey T, Flynt A, Lai E, Beal MF, Lin MT: MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 2010, 5:e15546.
47. Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, Vance JM, Outeiro TF, Wang L, Borovecki F, Ferreira JJ, Oliveira SA: Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson's disease. PLoS One 2011, 6:e25443.
48. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM: microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 2007, 8:R27.
49. Unden A, Tatemoto K, Mutt V, Bartfai T: Neuropeptide Y receptor in the rat brain. Eur J Biochem 1984, 145:525-530.
50. Bocchio-Chiavetto L, Maffioletti E, Bettinsoli P, Giovannini C, Bignotti S, Tardito D, Corrada D, Milanesi L, Gennarelli M: Blood microRNA changes in depressed patients during antidepressant treatment. EurNeuropsychopharmacol 2013, 23:602-611.
51. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E: Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009, 4:e7440.
52. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
53. FASTX-Toolkit. [http://hannonlab.cshl.edu/fastx_toolkit/].
54. Friedländer MR, Mackowiak SD, Li N, Chen W, Rajewsky N: miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 2012, 40:37-52.
55. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. JMolecular Biol 1990, 215:403-410.
56. Kozomara A, Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-157.
57. Lestrade L, Weber MJ: snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res 2006, 34:D158-162.
58. Ensembl. [ftp://ftp.ensembl.org/pub/release-67/fasta/homo_sapiens/ncrna/].
59. Bu D, Yu K, Sun S, Xie C, Skogerbo G, Miao R, Xiao H, Liao Q, Luo H, Zhao G, Zhao H, Liu Z, Liu C, Chen R, Zhao Y: NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res 2012, 40:D210-215.
60. GEO Database. [http://www.ncbi.nlm.nih.gov/geo/].
61. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
62. Hochberg Y: A sharper bonferroni procedure for multiple tests of significance. Biometrica 1988, 75:185-193.
63. Team R: R: A Languageand Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing 2008.
64. miRDB. [http://mirdb.org/miRDB/].
65. Wang X: miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14:1012-1017.
66. Wang X, El Naqa IM: Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008, 24:325-332.
67. TargetScan. [http://www.targetscan.org/vert_50/seedmatch.html].
68. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
69. GeneTrail. [http://genetrail.bioinf.uni-sb.de/].
70. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, Elnakady YA, Muller R, Meese E, Lenhof HP: GeneTrail-advanced gene set enrichment analysis. Nucleic Acids Res 2007, 35:W186-192.
71. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat SocB 1995, 57:289-300.
72. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q: An analysis of human microRNA and disease associations. PLoS One 2008, 3:e3420.